Burnham Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Burnham Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$20.1M	Buy	234,135 +200,970	+606%	+$18M	5.59%	3
2016 Q1	$2.82M	Sell	33,165 -1,425	-4%	-$127K	0.9%	32
2015 Q4	$3.9M	Sell	34,590 -30	-0.1%	-$3.26K	1.07%	24
2015 Q3	$3.5M	Buy	34,620 +1,980	+6%	+$237K	0.92%	32
2015 Q2	$4.01M	Buy	32,640 +210	+0.6%	+$25.1K	0.93%	28
2015 Q1	$3.71M	Sell	32,430 -315	-1%	-$34.7K	0.85%	32
2014 Q4	$3.31M	Buy	32,745 +3,300	+11%	+$321K	0.75%	36
2014 Q3	$2.69M	Buy	29,445 +11,610	+65%	+$1.02M	0.59%	45
2014 Q2	$1.53M	Buy	+17,835	New	+$1.41M	0.34%	80

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Societe Generale $14.1B AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Burnham Asset Management's IBB Position: Q2 2016 in Review

Burnham Asset Management increased its iShares Biotechnology ETF (IBB) stake by 606% in Q2 2016, buying an estimated $18M and bringing the position to 234,135 shares worth $20.1M. The position accounts for 5.59% of the portfolio, ranked #3.

Burnham Asset Management first reported a position in IBB in Q2 2014 and has held it in 9 quarters since. 428 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

Burnham Asset Management held 234,135 shares of iShares Biotechnology ETF worth $20.1M as of Q2 2016.
Burnham Asset Management bought 200,970 iShares Biotechnology ETF shares in Q2 2016, an estimated $18M.
iShares Biotechnology ETF made up 5.59% of Burnham Asset Management's portfolio in Q2 2016, its #3 holding.
Burnham Asset Management first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 9 quarters since.
428 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.